vs
A.O.史密斯（AOS）与NEOGENOMICS INC（NEO）财务数据对比。点击上方公司名可切换其他公司
A.O.史密斯的季度营收约是NEOGENOMICS INC的4.8倍（$912.5M vs $190.2M）。NEOGENOMICS INC同比增速更快（10.6% vs 0.0%）。A.O.史密斯自由现金流更多（$165.5M vs $-6.5M）。过去两年NEOGENOMICS INC的营收复合增速更高（10.3% vs -3.4%）
A.O.史密斯是美国知名的家用及商用热水器、锅炉生产商，也是北美规模最大的热水器制造销售商，在亚洲市场还供应水处理和净化产品。公司在全球共有27个站点，包括北美5座生产基地，以及位于印度班加罗尔、中国南京、荷兰费尔德霍芬的工厂。
新基因组公司（NeoGenomics）是美国一家经CLIA认证的临床实验室企业，提供药企服务与信息服务，专注于癌症基因诊断检测，旗下检测服务涵盖细胞遗传学、荧光原位杂交（FISH）、流式细胞术、免疫组化、解剖病理学及分子遗传学等多个领域，为肿瘤相关诊断提供专业支持。
AOS vs NEO — 直观对比
营收规模更大
AOS
是对方的4.8倍
$190.2M
营收增速更快
NEO
高出10.6%
0.0%
自由现金流更多
AOS
多$172.0M
$-6.5M
两年增速更快
NEO
近两年复合增速
-3.4%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $912.5M | $190.2M |
| 净利润 | $125.4M | — |
| 毛利率 | 38.4% | 43.8% |
| 营业利润率 | 17.9% | -7.1% |
| 净利率 | 13.7% | — |
| 营收同比 | 0.0% | 10.6% |
| 净利润同比 | 14.3% | — |
| 每股收益（稀释后） | $0.89 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AOSNEO
| Q4 25 | $912.5M | $190.2M | ||
| Q3 25 | $942.5M | $187.8M | ||
| Q2 25 | $1.0B | $181.3M | ||
| Q1 25 | $963.9M | $168.0M | ||
| Q4 24 | $912.4M | $172.0M | ||
| Q3 24 | $902.6M | $167.8M | ||
| Q2 24 | $1.0B | $164.5M | ||
| Q1 24 | $978.8M | $156.2M |
净利润AOSNEO
| Q4 25 | $125.4M | — | ||
| Q3 25 | $132.0M | $-27.1M | ||
| Q2 25 | $152.2M | $-45.1M | ||
| Q1 25 | $136.6M | $-25.9M | ||
| Q4 24 | $109.7M | — | ||
| Q3 24 | $120.1M | $-17.7M | ||
| Q2 24 | $156.2M | $-18.6M | ||
| Q1 24 | $147.6M | $-27.1M |
毛利率AOSNEO
| Q4 25 | 38.4% | 43.8% | ||
| Q3 25 | 38.7% | 42.8% | ||
| Q2 25 | 39.3% | 42.6% | ||
| Q1 25 | 38.9% | 43.6% | ||
| Q4 24 | 37.1% | 44.9% | ||
| Q3 24 | 37.4% | 44.6% | ||
| Q2 24 | 38.7% | 44.1% | ||
| Q1 24 | 39.3% | 41.9% |
营业利润率AOSNEO
| Q4 25 | 17.9% | -7.1% | ||
| Q3 25 | 18.6% | -14.4% | ||
| Q2 25 | 20.4% | -26.3% | ||
| Q1 25 | 19.1% | -16.6% | ||
| Q4 24 | 10.1% | -10.7% | ||
| Q3 24 | 19.5% | -12.6% | ||
| Q2 24 | 21.9% | -13.3% | ||
| Q1 24 | 22.0% | -19.6% |
净利率AOSNEO
| Q4 25 | 13.7% | — | ||
| Q3 25 | 14.0% | -14.4% | ||
| Q2 25 | 15.0% | -24.9% | ||
| Q1 25 | 14.2% | -15.4% | ||
| Q4 24 | 12.0% | — | ||
| Q3 24 | 13.3% | -10.5% | ||
| Q2 24 | 15.2% | -11.3% | ||
| Q1 24 | 15.1% | -17.3% |
每股收益（稀释后）AOSNEO
| Q4 25 | $0.89 | — | ||
| Q3 25 | $0.94 | — | ||
| Q2 25 | $1.07 | — | ||
| Q1 25 | $0.95 | — | ||
| Q4 24 | $0.75 | — | ||
| Q3 24 | $0.82 | — | ||
| Q2 24 | $1.06 | — | ||
| Q1 24 | $1.00 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $193.2M | $159.6M |
| 总债务越低越好 | $155.0M | $341.9M |
| 股东权益账面价值 | $1.9B | $836.6M |
| 总资产 | $3.1B | $1.4B |
| 负债/权益比越低杠杆越低 | 0.08× | 0.41× |
8季度趋势，按日历期对齐
现金及短期投资AOSNEO
| Q4 25 | $193.2M | $159.6M | ||
| Q3 25 | $172.8M | $164.1M | ||
| Q2 25 | $177.9M | $154.7M | ||
| Q1 25 | $200.2M | $346.2M | ||
| Q4 24 | $276.1M | $367.0M | ||
| Q3 24 | $255.6M | $362.0M | ||
| Q2 24 | $233.3M | $355.1M | ||
| Q1 24 | $303.1M | $331.9M |
总债务AOSNEO
| Q4 25 | $155.0M | $341.9M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $193.2M | $541.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益AOSNEO
| Q4 25 | $1.9B | $836.6M | ||
| Q3 25 | $1.8B | $838.3M | ||
| Q2 25 | $1.8B | $854.0M | ||
| Q1 25 | $1.9B | $888.3M | ||
| Q4 24 | $1.9B | $902.3M | ||
| Q3 24 | $1.9B | $908.2M | ||
| Q2 24 | $1.9B | $915.9M | ||
| Q1 24 | $1.9B | $923.4M |
总资产AOSNEO
| Q4 25 | $3.1B | $1.4B | ||
| Q3 25 | $3.2B | $1.4B | ||
| Q2 25 | $3.2B | $1.4B | ||
| Q1 25 | $3.3B | $1.6B | ||
| Q4 24 | $3.2B | $1.6B | ||
| Q3 24 | $3.2B | $1.6B | ||
| Q2 24 | $3.2B | $1.6B | ||
| Q1 24 | $3.2B | $1.6B |
负债/权益比AOSNEO
| Q4 25 | 0.08× | 0.41× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.10× | 0.60× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $183.1M | $1.3M |
| 自由现金流经营现金流 - 资本支出 | $165.5M | $-6.5M |
| 自由现金流率自由现金流/营收 | 18.1% | -3.4% |
| 资本支出强度资本支出/营收 | 1.9% | 4.1% |
| 现金转化率经营现金流/净利润 | 1.46× | — |
| 过去12个月自由现金流最近4个季度 | $546.0M | $-21.8M |
8季度趋势，按日历期对齐
经营现金流AOSNEO
| Q4 25 | $183.1M | $1.3M | ||
| Q3 25 | $255.4M | $8.9M | ||
| Q2 25 | $139.6M | $20.3M | ||
| Q1 25 | $38.7M | $-25.3M | ||
| Q4 24 | $221.9M | $9.8M | ||
| Q3 24 | $195.9M | $9.2M | ||
| Q2 24 | $57.4M | $13.9M | ||
| Q1 24 | $106.6M | $-25.9M |
自由现金流AOSNEO
| Q4 25 | $165.5M | $-6.5M | ||
| Q3 25 | $240.6M | $570.0K | ||
| Q2 25 | $122.5M | $14.0M | ||
| Q1 25 | $17.4M | $-29.8M | ||
| Q4 24 | $191.3M | $-1.8M | ||
| Q3 24 | $163.4M | $-1.6M | ||
| Q2 24 | $34.5M | $814.0K | ||
| Q1 24 | $84.6M | $-31.5M |
自由现金流率AOSNEO
| Q4 25 | 18.1% | -3.4% | ||
| Q3 25 | 25.5% | 0.3% | ||
| Q2 25 | 12.1% | 7.7% | ||
| Q1 25 | 1.8% | -17.8% | ||
| Q4 24 | 21.0% | -1.0% | ||
| Q3 24 | 18.1% | -0.9% | ||
| Q2 24 | 3.4% | 0.5% | ||
| Q1 24 | 8.6% | -20.2% |
资本支出强度AOSNEO
| Q4 25 | 1.9% | 4.1% | ||
| Q3 25 | 1.6% | 4.4% | ||
| Q2 25 | 1.7% | 3.5% | ||
| Q1 25 | 2.2% | 2.7% | ||
| Q4 24 | 3.4% | 6.7% | ||
| Q3 24 | 3.6% | 6.4% | ||
| Q2 24 | 2.2% | 8.0% | ||
| Q1 24 | 2.2% | 3.6% |
现金转化率AOSNEO
| Q4 25 | 1.46× | — | ||
| Q3 25 | 1.93× | — | ||
| Q2 25 | 0.92× | — | ||
| Q1 25 | 0.28× | — | ||
| Q4 24 | 2.02× | — | ||
| Q3 24 | 1.63× | — | ||
| Q2 24 | 0.37× | — | ||
| Q1 24 | 0.72× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AOS
| North America Segment | $713.7M | 78% |
| Rest Of World | $158.3M | 17% |
| Other | $40.5M | 4% |
NEO
| Client Direct Billing | $133.4M | 70% |
| Commercial Insurance | $31.4M | 17% |
| Medicare And Other Governmental | $25.4M | 13% |
